abstract |
This invention relates to anti-OX40L antibodies and in particular, anti-IX40L antibodies and variants thereof that contain an Fc part derived from human origin and do not bind the complement Clq factor. These antibodies have new and inventive properties that cause a benefit for a patient suffering from inflammatory diseases. |